Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Chemomab Therapeutics Ltd. | 6,875 | reported | 16 Mar 2023 | tx 24+171,244−2,409 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 688 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,875 | 0.00 USD | deriv |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 16 Nov 2022 | SALE | Chemomab Therapeutics Ltd. | 2,409 | 2.00 USD | |
| 07 Mar 2022 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 16 Mar 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 688 | 0.00 USD | deriv |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 18 May 2022 | PURCHASE | Chemomab Therapeutics Ltd. | 2,000 | 3.19 USD | |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 16 Mar 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 688 | 0.00 USD | deriv |
| 14 Mar 2022 | PURCHASE | Chemomab Therapeutics Ltd. | 2,000 | 4.56 USD | |
| 14 Mar 2022 | PURCHASE | Chemomab Therapeutics Ltd. | 2,000 | 4.30 USD | |
| 14 Mar 2022 | PURCHASE | Chemomab Therapeutics Ltd. | 2,000 | 4.20 USD | |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 16 Mar 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 688 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 06 Dec 2021 | PURCHASE | Chemomab Therapeutics Ltd. | 2,000 | 7.43 USD | |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 16 Mar 2021 | PURCHASE | Chemomab Therapeutics Ltd. | 2,409 | 41.51 USD | |
| 16 Mar 2021 | PURCHASE | Chemomab Therapeutics Ltd. | 688 | 0.00 USD | deriv |
| 16 Jul 2020 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 55,000 | 0.00 USD | deriv |